Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Beware Of Tainted Weight Loss Pills, Warns FDA

Beware Of Tainted Weight Loss Pills, Warns FDA

Consumers are advised not to purchase or use "Japan Rapid Weight Loss Diet Pills", a product for weight loss, as they contain a cancer-causing agent, warns the FDA.

The "Japan Rapid Weight Loss Pills", which are available in three different colors namely, green, yellow and blue, are sold on various websites, such as www.ebay.com, and distributed by a company called Xiushentang.

A laboratory analysis by the FDA has confirmed that these weight loss diet pills contain undeclared Phenolphthalein and Sibutramine.

Phenolphthalein is a chemical capable of potentially damaging or even causing mutations in a person's DNA. The FDA has classified Phenolphthalein as "not generally recognized as safe and effective."

Sibutramine is a substance known to substantially increase blood pressure and/or pulse rate in some patients.

Remember, Abbott Laboratories' obesity drug Meridia, which was pulled off the market in October 2010 due to increased risk of heart attack and stroke? The active ingredient in Meridia was also Sibutramine.

The FDA in a statement said that consumers should stop using these products immediately and throw them away. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.